PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 27, 2026British Journal of Haematology0 citations

Beyond neutropenia: Immunological evaluation of patients with Shwachman‐Diamond syndrome

View Full Paper
NGNicholas J. GloudeKBKaryn BrundigeSLSara Loveless

Key Points

  • This research aims to map the immunological profile of patients with Shwachman-Diamond syndrome to understand their immune function better.
  • Retrospective analysis of patients with biallelic mutations in SBDS from the Shwachman-Diamond Syndrome Registry (n=223) and clinical follow-ups (n=6).
  • Data extracted from chart reviews and included immunological assessments at 409 time points.
  • Evaluation focused on B-cell counts and immunoglobulin levels in patients with SDS.
  • Identified low absolute B cells in 31% of patients and low IgM in 30% of patients.
  • Patients with low B cells faced increased infection risks, especially with concurrent low IgG levels.
  • Recommendation for baseline immunological evaluations including full blood counts and lymphocyte subpopulations for patients with SDS.

Abstract

Summary Shwachman‐Diamond syndrome (SDS) is an inherited bone marrow failure syndrome characterized by neutropenia and pancreatic insufficiency. The current understanding of immune function in SDS is limited. We performed a retrospective study of the US‐based Shwachman‐Diamond Syndrome Registry (SDSR) to characterize the immunological profile of patients with SDS. Data were obtained from chart review of patients with biallelic mutations in SBDS enrolled on the SDSR ( n = 223) or followed clinically at participating institutions with local IRB approval ( n = 6). Immunological data were available from 409 time points on 98 individuals with SDS at healthy time points. We identified limited immune deficits, largely quantitative changes in the B‐cell compartment in a subset of patients with SDS including low absolute B cells in 31% of patients and low IgM in 30% of patients. Patients with SDS with low B cells may be at increased risk for sinopulmonary, skin or soft tissue infections particularly if they also have low IgG levels. These data support a baseline immunological evaluation, including a full blood count, lymphocyte subpopulations and immunoglobulin levels, for patients with SDS. However, it is reasonable to reserve more detailed assessments for patients with recurrent or severe infections.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gloude et al. (2026) studied this question.

synapsesocial.com/papers/6a168a090c924ddd1bd58bb6https://doi.org/10.1111/bjh.70553
Ask AI
Helpful
Bookmark
Share
View Full Paper